J Gastroenterol (2017) 52:1077–1078 DOI 10.1007/s00535-017-1365-7 LETTE R T O T HE EDI T OR Response to the Letter by Lucijanic et al., regarding our manuscript ‘‘Management and outcome of gastro-intestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs’’ 1,2 Jan Beyer-Westendorf Received: 7 June 2017 / Accepted: 14 June 2017 / Published online: 28 June 2017 Japanese Society of Gastroenterology 2017 We read with interest the comments by Lucijanic and co- value that we do not believe should be assigned to it. As we workers, regarding our article ‘‘Management and outcome have clearly pointed out, our ﬁndings of differences in of gastrointestinal bleeding in patients taking oral antico- bleeding location, management and outcome between agulants or antiplatelet drugs’’. NOAC, VKA and AP are purely hypothesis-generating. The main criticism relates to the fact that our cohorts They are important ﬁrst evaluations of a clinically relevant represented different populations with regard to baseline question, which, to our knowledge, have not been addres- characteristics and to the indication for antithrombotic sed in such detail before. Now that we did demonstrate therapy. We completely agree with this observation and clinically relevant differences between gastrointestinal want to add that the data for
Journal of Gastroenterology – Springer Journals
Published: Jun 28, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera